It's the first test in the United States that can be used between 11 and 14 weeks gestation to determine the risk of preeclampsia before 34 weeks of pregnancy, Labcorp said in a news release ...
Labcorp (LH) announced the commercial availability of its new H5 bird flu molecular test to aid in the diagnosis of human infection with H5 ...
Labcorp developed this commercially available test with support from the CDC to increase access and testing capacity to support public health preparedness strategies. "As we continue to monitor ...
(RTTNews) - Labcorp Holdings Inc. (LH), Tuesday announced the launch of H5 bird flu molecular test in the U.S., except the New York state, to detect the potential cases of bird flu in humans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results